Relating to authorizing patients with certain terminal illnesses to access certain investigational drugs, biological products, and devices that are in clinical trials.
Relating to the purchase of certain insurance coverage and the performance of related risk management services for certain university systems and the component institutions of those systems.
Relating to the development of antifraud educational programs by the Texas Department of Insurance and acceptance of gifts, grants, and donations for the department's fraud unit.